Vice President Acute Care Services, Professor of Surgical Oncology, MD Anderson Cancer Center
General Surgery
Dr. Paul F. Mansfield, MD
|
|
Give Review
Paul F. Mansfield, MD works in the field of General Surgery. He went to Jefferson Medical College. He received 4 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Fellow (FACS)". Paul Mansfield is a published doctor and has 77 publications published. The lastest was: 'Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma.' Paul Mansfield accepts all Medicare patients.
Publications
- Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric AdenoCarcinoma.
- Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
- Comprehensive geriatric assessment in patients with gastric and gastroesophageal adenoCarcinoma undergoing gastrectomy.
- A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous AdenoCarcinoma of the Appendix.
- Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
- Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the deLivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in...
- Serious postoperative infections following resection of common solid Tumors: outcomes, costs, and impact of hospital surgical volume.
- Improving the AJCC/TNM staging for adenoCarcinomas of the appendix: the prognostic impact of histological grade.
- High-level Microsatellite Instability in Appendiceal Carcinomas.
- Pathologic complete response in poorly differentiated adenoCarcinomas of the appendix: A case series.
- Surgical approaches to gastric Cancer.
- Localized Gastric Cancer Treated with Chemoradation without Surgery: UTMD Anderson Cancer Center Experience.
- Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenoCarcinoma.
- Conditional survival estimates improve over 5 years for melanoma survivors with node-positive Disease.
- Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based Analysis.
- Multimodality approaches to localized gastric Cancer.
- Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience.
- Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C.
- Lymph node ratio predicts Disease-specific survival in melanoma patients.
- Patient with advanced gastric Cancer responds twice to the same systemic therapy.
- Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
- Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
- The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.
- Incidence, natural history, and patterns of locoregional recurrence in gastric Cancer patients treated with preoperative chemoradiotherapy.
- Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.
- Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III Disease.
- Chemoradiation therapy for potentially resectable gastric Cancer: clinical outcomes among patients who do not undergo planned surgery.
- Melanoma adrenal metastasis: natural history and surgical management.
- Peritoneal dissemination of non-carcinoid primary appendiceal Cancer.
- Cytoreductive surgery and perioperative intraperitoneal chemotherapy for coloRectal carcinomatosis: if at first you don't succeed....
- Pneumoperitoneum in the Cancer patient.
- Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
- Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric Cancer.
- Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
- Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenoCarcinoma of the stomach or...
- Cost effectiveness of adjuvant interferon in node-positive melanoma.
- Factors influencing the volume-outcome relationship in gastrectomies: a population-based study.
- Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
- Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.
- Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
- Outcome of gastric Cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival.
- Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control Analysis.
- Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma.
- Ethnic differences among patients with cutaneous melanoma.
- Invasive squamous cell Carcinoma of the skin: defining a high-risk group.
- Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
- Metastatic melanoma to lymph nodes in patients with unknown primary sites.
- Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
- Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.
- In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control Analysis.
- Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction.
- Adjuvant and neoadjuvant therapy for gastric Cancer.
- Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
- Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy.
- Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: Analysis of a single institution's experience over 15 years.
- Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric Carcinoma.
- A critical assessment of adjuvant radiotherapy for Inguinal lymph node metastases from melanoma.
- Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.
- ZD6474, a Vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhi...
- Lymphadenectomy for gastric Cancer.
- Biochemotherapy in patients with metastatic anoRectal mucosal melanoma.
- p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma.
- Management of peritoneal Carcinomatosis: is an answer at hand?
- Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
- Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
- Combined-modality therapy for gastric Cancer.
- Subaquatic laparoscopy for staging of intraAbdominal malignancy.
- Sphincter-sparing local excision and adjuvant radiation for Anal-rectal melanoma.
- AdenoCarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome.
- DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma.
- Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma.
- Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and Disease recurrence in melanoma patients.
- Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction Carcinoma.
- Adjuvant irradiation for axillary metastases from malignant melanoma.
- CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction Carcinoma: results of a phase II study.
- Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric Cancer.
Schools
Jefferson Med CollThos Jefferson Univ
Pennsylvania Hospital
University Tex MD Anderson Canc Center
Procedures Preformed
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Colectomy
- Cystectomy
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Atelectasis
- Breast Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
Pennsylvania Hospital - University of Pennsylvania Health System -
Jefferson Medical College
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Similar Doctors
|
|
Dr. Charles S. Peter Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Timothy J. Sehorn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith F. Fournier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Voravit Wongsa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick B. Garvey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian D. Badgwell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Avo Artinyan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark H. Edelman, MD |
|
|
Dr. Mary T. Austin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtney J. El, MD |
|
|
Dr. Vid Fikfak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brittany Serratos, MD |
|
|
Dr. Aaron Scott, MD |